Dr. Beth Karlan is a leader in the field of research on early detection of ovarian cancer. She has received research grants from the Department of Defense, National Institutes of Health and the American Cancer Institute. Her research interests include the genetic definition and phenotypic determinants of human ovarian carcinomas, molecular biomarker discovery and inherited cancer susceptibility. This year, she is our winner of the Rosalind Franklin Excellence in Ovarian Cancer Research Award due to her commitment to innovative ovarian cancer research.
Related Topics
FDA Approves First Ovarian Cancer Immunotherapy for PD-L1–Positive Platinum-Resistant Disease
The U.S. Food and Drug Administration (FDA) has approved the first immunotherapy regimen shown to extend survival in a subset of ovarian cancer patients. The FDA authorized Keytruda (pembrolizumab), made by Merck, in combination with chemotherapy, for PD-L1–positive, platinum-resistant epithelial ovarian, fallopian tube, and primary peritoneal cancers. Keytruda plus weekly Taxol (paclitaxel), with or without … Continued
The Overview: January 2026
Ovarian Cancer Research Alliance (OCRA) has announced a collaboration with OPERATION WIPE OUT, an initiative that has demonstrated meaningful success reducing cervical cancer risk in Alabama through prevention-focused education and access to care. Drawing on this proven public-health framework, OCRA will adapt and expand the model nationwide—bringing practical, evidence-based cervical cancer prevention strategies to communities … Continued
New Support Sessions for the Gynecologic Cancer Community
Ovarian Cancer Research Alliance (OCRA) has expanded its free, online support offerings with several new weekly sessions for individuals diagnosed with gynecologic cancers, as well as caregivers and family members. These include cervical, vaginal, and vulvar cancer support, caregiver grief support, Spanish-language sessions, and creative wellness programs. OCRA’s support sessions are facilitated by oncology social work professionals. … Continued